Home
Progress Development Report: Evolutionary-Aware Target Discovery
Welcome to the Pandemic Preparedness Progress Report. This portal serves as the official documentation for the development of our Evolutionary-Aware Target Discovery Pipeline, designed to identify robust and mutation-resistant diagnostic targets for emerging pathogens.
Executive Summary
Pathogens with epidemic potential, particularly those causing Acute Respiratory Infections (ARI) such as Influenza A and Coronaviruses, exhibit high mutation rates. Conventional molecular diagnostics (e.g., RT-PCR and Recombinase Polymerase Amplification - RAA) frequently suffer from diagnostic escape due to primer mismatch at target sites.
To address this challenge, our pipeline integrates global genomic surveillance data with phylogenetic and evolutionary selection pressure analyses. By mapping codon-by-codon evolutionary dynamics, the pipeline identifies target regions under strong purifying selection (negative selection) and high ancestral conservation. Targeting these genetically constrained regions ensures the longevity and diagnostic sensitivity of designed assays, mitigating the risk of diagnostic escape.
Technical Pipeline Workflow
The target discovery pipeline is structured into four main phases spanning ten core modules (M01 to M10):
| Phase | Core Modules | Objective & Key Activities |
|---|---|---|
| Phase 1: Genomic & Phylodynamics | M01 – M04 | Acquisition, quality control, multiple sequence alignment, and phylogenetic tree reconstruction. |
| Phase 2: Selection & Conservation | M05 – M07 | Mapping of codon-by-codon evolutionary selection pressure (HyPhy) and ancestral sequence conservation scoring. |
| Phase 3: Design & Specificity | M08 – M09 | Design of RAA primers/probes (using PrimerLab) and BLAST-based specificity filtering. |
| Phase 4: Simulated Evaluation | M10 | Simulated multi-metric in-silico validation of candidates across global databases. |
Consortium & Funding
This development initiative is part of the national project “Peningkatan Kapasitas Laboratorium untuk Deteksi Patogen Berpotensi Pandemik bagi Human Dalam Persiapan Menghadapi Pandemi” (FY 2026), supported and funded by the Badan Riset dan Inovasi Nasional (BRIN).
The project is carried out through a multi-institutional research consortium:
- Pusat Riset Biomedis, Organisasi Riset Kesehatan, BRIN
- Universitas Gadjah Mada (UGM)
- Universitas Indonesia (UI)
- Universitas Telkom
- University of Bern, Switzerland (International Collaborator)
- Tokyo University of Agriculture and Technology, Japan (International Collaborator)